Johnson Financial Group Inc. Sells 1,512 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Johnson Financial Group Inc. decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 83.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 291 shares of the company's stock after selling 1,512 shares during the period. Johnson Financial Group Inc.'s holdings in HCA Healthcare were worth $96,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter worth about $36,000. Activest Wealth Management boosted its holdings in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. lifted its position in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Finally, Eastern Bank acquired a new stake in HCA Healthcare during the 4th quarter valued at $62,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Barclays decreased their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Royal Bank of Canada decreased their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday. Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. Finally, Robert W. Baird reiterated a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $381.13.

Insider Activity

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded down $2.15 during trading on Thursday, reaching $342.93. The stock had a trading volume of 1,148,001 shares, compared to its average volume of 1,398,968. The business's 50-day moving average price is $331.02 and its 200 day moving average price is $331.49. The stock has a market capitalization of $84.43 billion, a PE ratio of 15.61, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same period in the previous year, the firm posted $5.36 earnings per share. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. HCA Healthcare's payout ratio is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.